European Pharmaceutical Review

OCTOBER 27, 2023

Benefits of The Future Clinical Trials Bill Chiefly, the Bill’s goal is to increase patient participation and overall, ensure clinical trials have the highest levels of safety while enabling greater regulatory pragmatism, the author explained. If achieved, this would boost the UK’s competitiveness as a leading international site for trials.

Ethics 105

Ethics Medicine Education Competition 105

European Pharmaceutical Review

JULY 25, 2022

The proposal is a result of a comprehensive revision of the existing EU legislation, including the consultation of a wide range of BTC stakeholders and international organisations, such as the European Directorate for the Quality of Medicines & HealthCare (EDQM) of the Council of Europe.

Safety 116

Safety Consulting Healthcare Healthcare 116

European Pharmaceutical Review

MAY 11, 2023

Notably, data from LT-001, a 15-year ongoing observational study following the Phase I START patients, showed that children treated after presenting symptoms of SMA maintained all previously achieved milestones up to 7.5 percent of Europe’s annual healthcare spend. years post-dosing. Stakeholder education is critical to achieving this.

Food and Drug Administration 95

Food and Drug Administration Government Healthcare Healthcare 95

pharmaphorum

JANUARY 19, 2023

It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes. When Milburn and Blair introduced competition in 2004-2008 it did start to make a difference.”

Pharma 75

Pharma Competition Healthcare Healthcare 75

PM360

SEPTEMBER 15, 2022

And can the mistrust and skepticism minority communities have toward the healthcare system be overcome to spread crucial disease awareness? Patient Advocacy. So having this level of collaboration is quite remarkable, and in the long run will really serve patients and providers.”. But what do these collaborations look like?

Education 105

Education Physicians Pharma Patients 105

European Pharmaceutical Review

DECEMBER 19, 2022

Nonetheless, some stakeholders remain concerned with this new approach given the complexity of biological medicines and the need for patients to be treated individually and have called for further discussions with regulators and all stakeholders. Chris was named a ‘Rising Star’ in the 2022 Legal 500 Rankings for Life Sciences and Healthcare.

Medicine 52

Medicine Biopharma Safety Food 52

European Pharmaceutical Review

AUGUST 23, 2022

To achieve this objective, the regulation amends Directive 2011/24/EU on the application of patients’ rights in cross?border border healthcare, specifically by repealing Article 15, which originally laid down the modalities and principles for co-operation between Member States in assessing new health technologies. About the authors.

Consulting 98

Consulting Medical Healthcare Healthcare 98

PM360

APRIL 7, 2023

The Lupus ABC will allow lupus patients to collaborate with the FDA, other federal agencies, medical societies, industry, academic clinical researchers, and scientists to advance the development of breakthrough treatments for lupus. The worst outbreak occurred in Angola in 2004-2005, where there were 252 cases and 227 deaths.

Healthcare 52

Healthcare Healthcare Marketing Government 52

Pharmaceutical Technology

FEBRUARY 24, 2023

The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinical trials, supply chain security and shortages, and environmental impact. The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years.

Pharma 64

Pharma Medicine Competition Marketing 64

Pharmaceutical Technology

OCTOBER 5, 2022

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs.

Government 59

Government Specialization Physicians Education 59

PM360

SEPTEMBER 28, 2022

This was back in 2004/2005 when we were just hearing about biosimilars for the first time and they were the great unknowns. Ultimately, it could lead to several outgrowths, such as a decline in overall drug pricing, more access to treatment options for a greater number of patients, or additional patient services being provided.

Competition 98

Competition Marketing Manufacturing Biopharma 98

European Pharmaceutical Review

JULY 20, 2023

Background on BCT legislation in the EU Every year EU patients are treated with 25 million blood transfusions, a million cycles of medically assisted reproduction, over 35,000 transplants of stem cells and hundreds of thousands of replacement tissues.

Safety 75

Safety Distribution Food Medical 75

pharmaphorum

AUGUST 4, 2022

Such information is crucial for customer service staff as they must be well-positioned to keep up with the compliance standards of their practice and be well informed to offer patients up-to-date information about the benefits of a prescribed drug. In addition, she worked as head of inspectorate and licensing for the MHRA from 2004-2006.

Recruitment 92

Recruitment Pharma Training Pharmaceutical manufacturing 92

CloserIQ

OCTOBER 10, 2018

Kyruus is revolutionizing healthcare with its data-driven system that makes it easier for healthcare system to match patients to appropriate providers. Founded 2004. Devoted Health is a healthcare company that helps seniors navigate the complex healthcare system. Founded 2004. Founded 2010.

Sales 76

Sales Management Education Marketing 76

World of DTC Marketing

MARCH 17, 2022

What treatment works in one patient may not work in another but we have to keep trying to beat cancer anyway we can. In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017. In 2018 cancer patients in the U.S.

Food and Drug Administration 255

Food and Drug Administration Medical Patients Ethics 255

European Pharmaceutical Review

FEBRUARY 7, 2023

In addition, the devices must not present an unacceptable risk to patient and user health and safety as established in Articles 94 and 95 of the MDR. Edward Turtle is a products lawyer, regulatory advisor and litigator with particular experience in the healthcare, technology and consumer product sectors.

Medical 117

Medical Government Marketing Medicine 117

Pharmaceutical Technology

JULY 4, 2022

Servier referred us to a statement announcing that it is suspending the start of new clinical trials in Russia and Belarus, as well as recruitment of new patients for ongoing trials, and that it will donate the profits from its subsidiary in Russia this year to support humanitarian action in Ukraine.

Pharma 122

Pharma Food and Drug Administration Manufacturing Medicine 122

Pharmaceutical Technology

JULY 10, 2008

Some companies using virtual technology have already reduced clinical trial times by 40% and reduced the number of patients required for testing by two thirds, says Arlington. Even so, current figures show firms’ biggest portion of spend is still on marketing and administration at 33.1%,

Food and Drug Administration 52

Food and Drug Administration Medicine Pharmaceutical Government 52

Cadensee

JULY 20, 2021

He is one of the first advocates for patient centric health care more than a decade ago when patient opinions and requests were not part of the equation in the system. Uri founded and continues to contribute insights through his digital magazine, e-Pochonder and is one of the first advocates for patient centric health care.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52

Pharmaceutical Technology

APRIL 12, 2023

This is to ensure patient safety, as outlined in The Medicines for Human Use (Clinical Trials) Regulations 2004. Current regulations for preclinical research In the UK, current regulation requires that all new medicines and vaccines be tested on animal models in preclinical studies, before being tested in humans in clinical trials.

Pharma 98

Pharma Food and Drug Administration Safety Medicine 98